Pulmonology

How do e-cigarettes fit into the cardiovascular health paradigm? What more needs to be learned?

Breaking down the details of the E3 trial, and what more needs to be found in the follow-up.

New ACC findings show smokers given nicotine or non-nicotine e-cigarettes better in 12-week cessation than those just given counseling.

The Abbott-developed test platform is already used as a molecular point-of-care device for influenza A and B, Strep A, and respiratory syncytial virus.

Allergic rhinitis is the most frequent atopic coexisting disease in the LIBERTY ASTHMA VENTURE study.

New research is shedding light on national trends in outcomes and predictors of in-hospital mortality for patients undergoing surgical embolectomy for acute pulmonary embolism.

A pediatric version of the ASTHMAXcel mobile application will include games.

Digital tools can be leveraged to help treat more patients remotely.

Results of a study show the efficacy of an artificial intelligence chatbot for patients with asthma and pregnant women.

In the phase 2 PIONEER trial, patients taking avapritinib self-reported improvements in quality of life.

New expanded analysis from the IMPACT trial shows FF/UMEC/VI's benefit versus dual inhaler therapies.

About 1 in every 20 adult Americans now reguarly uses vaping and e-cigarette products.

The vaccine is safe and effective in preventing pneumococcal disease and pneumonia.

A new asthma study will leverage real-time data in the next 10 years.

Doctors of all fields, including pulmonologists, are coming together to collaborate on research regarding the ongoing threat of the coronavirus.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

The former SCCM president speaks on the risk of facing ICU-trained personnel shortages during the coronavirus spread.

Recent studies analyze the sensitivity and specificity for RT-PCR and chest CT for diagnosing coronavirus.

As medical knowledge continues to grow, Dennis Ledford. MD, explains the importance of doctors in different fields collaborating.

Roy Schoenberg, MD, MPH, discusses the populations that can most benefit from using telehealth tools and Medicare reimbursement obstacles.

With the spread of coronavirus increasing in the US, telehealth can be leveraged, but regulations need to be modified.

The approval is the third for the Boehringer Ingelheim-produced therapy and the first from the FDA for treating patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.

The Ready, Set, Food! co-founder discusses how research and federal advisory shapes parental understanding of immunotherapy and food allergy prevention.